These courses are intended for internal hospital staff.

Activity Description:

This course focuses on case-based and didactic presentations from experts in the treatment of the whole spectrum of gastrointestinal (GI) cancers, including esophageal, gastric, hepatocellular, pancreatic, small bowel, bile duct, anal and colorectal, and gallbladder. The primary goal of this series is to guide practicing physicians on integrating the best and most current evidence into day-to-day routine care for patients with GI cancers. This course brings a practical perspective on how to optimize multidisciplinary care for some of the more complex clinical management decisions. Topics discussed include locoregional modalities, the role of minimally invasive procedures, and state-of-the-art radiation modalities.

Target Audience:

This course is designed for medical, radiation and surgical oncologists; gastroenterology surgeons, gastroenterologists and hepatologists involved in cancer care; interventional radiologists; pharmacists; nurse practitioners; physician assistants; and nurses. Other healthcare professionals involved in the care of patients diagnosed with GI malignancies may benefit from this program.

Learning Objectives:

• Implement optimal course of treatment for patients with gastrointestinal cancers.
• Utilize multiple disciplinary approaches to determine diagnosis and treatment options, including radiological findings.
• Determine cancer staging using various imaging modalities of gastrointestinal cancers.
• Promote a multidisciplinary team approach by bridging gaps across the continuum of care in order to enhance the overall quality of patient-centered gastrointestinal cancer care.

Moderator:

Kian Modanlou, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.